News

Immunotherapies for GI and lung cancers evaluated in new studies
11/20/2023
A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.
Genomic testing can improve outcomes for people with advanced cancer, study shows
11/3/2023
Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.
Providence researchers contribute to 21 studies at SITC2023
11/20/2023
SITC 2023 provides a glimpse into scientific advances and breakthroughs in cancer immunotherapy by researchers from around the world.
Attend free virtual talk on lung cancer prevention and treatment
10/20/2023
Providence Cancer Institute lung cancer expert to present a virtual education talk on lung cancer screening, prevention and latest treatments.
New studies address unmet needs in treating triple-negative breast cancer
10/12/2023
Two new studies available at Earle A. Chiles Research Institute, at division of Providence Cancer Institute of Oregon, to evaluate new treatments for triple-negative breast cancer.
Dr. Urba receives award for his contributions to science and community
10/4/2023
Providence Cancer Institute of Oregon, and research director, Earle A. Chiles Research Institute, Walter J. Urba, M.D., Ph.D., receives award for his contributions to science and community.
Recognizing the important contributions of oncology APPs
9/25/2023
Providence Cancer Institute celebrates Advanced Practice Providers Week from September 25 to 29 and recognizes their important contributions more than 25 clinics and programs.
New division director and deputy director of Hematology and Medical Oncology share a vision
9/22/2023
Providence Cancer Institute of Oregon announces new division director and deputy director of Hematology and Medical Oncology.
New study aims to fill treatment gap for patients with endometrial cancer
9/18/2023
For Gynecologic Cancer Awareness Month, Providence Cancer Institute highlights a clinical trial that evaluates the safety and effectiveness of a new oral treatment for grade 1 endometrial cancer.
Grief and gratitude: Dr. Schmidt’s remarkable story of recovery after crash
7/27/2023
In 2021, Dr. Nicole Schmidt was driving around a curve when she saw a car headed straight for her. The crash sent her to a trauma center and started a journey of healing, learning and becoming.
Two new trials enrolling patients with rectal cancer and solid tumors
7/10/2023
A phase II trial tests FOLFOX or CAPOX versus FOLFIRINOX in patients with locally advanced rectal cancer, and a phase I trial evaluates TBio-4101 in patients with advanced solid tumors.
Promising results of Providence-sponsored trial published in npj Breast Cancer
7/3/2023
Final outcomes from a Providence Cancer Institute-sponsored phase Ib trial evaluating pembrolizumab with either weekly paclitaxel or flat-dose capecitabine in treating patients with metastatic TNBC.